AR-V7-a novel predictive and prognostic Biomarker Therapy Individualization in castration-resistant Prostate Cancer

被引：0
|
作者：
Oing, C. [1 ]
von Amsberg, G. [1 ]
Bokemeyer, C. [1 ]
机构：
[1] Univ Klinikum Hamburg Eppendorf, Med Klin Onkol Hamatol & Stammzelltransplantat Se, D-20246 Hamburg, Germany
来源：
ONKOLOGE | 2015年 / 21卷 / 09期
关键词：
ABIRATERONE ACETATE; ENZALUTAMIDE; DOCETAXEL;
D O I：
10.1007/s00761-015-3019-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：846 / 847
页数：2
相关论文
共 50 条
  • [31] Clinical implication of prognostic and predictive biomarkers for castration-resistant prostate cancer: a systematic review
    Shengri Tian
    Zhen Lei
    Zuo Gong
    Zhonghai Sun
    Dongyuan Xu
    Minhu Piao
    Cancer Cell International, 20
  • [32] Prognostic and Predictive Factors for Anti-androgen Withdrawal in Castration-resistant Prostate Cancer
    Murakami, Tomohiko
    Obata, Hirofumi
    Akitake, Naoko
    Shiota, Masaki
    Takeuchi, Ario
    Kashiwagi, Eiji
    Inokuchi, Junichi
    Tatsugami, Katsunori
    Eto, Masatoshi
    ANTICANCER RESEARCH, 2018, 38 (07) : 4115 - 4121
  • [33] Clinical implication of prognostic and predictive biomarkers for castration-resistant prostate cancer: a systematic review
    Tian, Shengri
    Lei, Zhen
    Gong, Zuo
    Sun, Zhonghai
    Xu, Dongyuan
    Piao, Minhu
    CANCER CELL INTERNATIONAL, 2020, 20 (01)
  • [34] Androgen receptor (AR) aberrations in castration-resistant prostate cancer
    Waltering, Kati K.
    Urbanucci, Alfonso
    Visakorpi, Tapio
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2012, 360 (1-2) : 38 - 43
  • [35] ANDROGRAPHOLIDE TARGETS AR PATHWAY IN CASTRATION-RESISTANT PROSTATE CANCER
    Liu, Chengfei
    Sun, Meng
    Lou, Wei
    Chun, Jaeyeon
    Nadiminty, Nagalakshmi
    Evans, Christopher
    Gao, Allen
    JOURNAL OF UROLOGY, 2011, 185 (04): : E167 - E167
  • [36] Re: Association of AR-V7 on Circulating Tumor Cells as a Treatment-Specific Biomarker with Outcomes and Survival in Castration-Resistant Prostate Cancer
    Taneja, Samir S.
    JOURNAL OF UROLOGY, 2016, 196 (04): : 1124 - 1124
  • [37] Efficacy of Cabazitaxel in Castration-resistant Prostate Cancer Is Independent of the Presence of AR-V7 in Circulating Tumor Cells
    Onstenk, Wendy
    Sieuwerts, Anieta M.
    Kraan, Jaco
    Van, Mai
    Nieuweboer, Annemieke J. M.
    Mathijssen, Ron H. J.
    Hamberg, Paul
    Meulenbeld, Hielke J.
    De Laere, Bram
    Dirix, Luc Y.
    van Soest, Robert J.
    Lolkema, Martijn P.
    Martens, John W. M.
    van Weerden, Wytske M.
    Jenster, Guido W.
    Foekens, John A.
    de Wit, Ronald
    Sleijfer, Stefan
    EUROPEAN UROLOGY, 2015, 68 (06) : 939 - 945
  • [38] Has the Time Arrived for Biomarker-Directed Therapy in Castration-Resistant Prostate Cancer?
    Taplin, Mary-Ellen
    Balk, Steven P.
    JAMA ONCOLOGY, 2015, 1 (05) : 577 - 579
  • [39] Constitutively Active AR-V7 Plays an Essential Role in the Development and Progression of Castration-Resistant Prostate Cancer
    Yuanyuan Qu
    Bo Dai
    Dingwei Ye
    Yunyi Kong
    Kun Chang
    Zhongwei Jia
    Xiaoqun Yang
    Hailiang Zhang
    Yao Zhu
    Guohai Shi
    Scientific Reports, 5
  • [40] Constitutively Active AR-V7 Plays an Essential Role in the Development and Progression of Castration-Resistant Prostate Cancer
    Qu, Yuanyuan
    Dai, Bo
    Ye, Dingwei
    Kong, Yunyi
    Chang, Kun
    Jia, Zhongwei
    Yang, Xiaoqun
    Zhang, Hailiang
    Zhu, Yao
    Shi, Guohai
    SCIENTIFIC REPORTS, 2015, 5
12345